Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,232 | 24,310 | 40,288 | 42,461 | 72,108 |
| Marketable Securities | 53,151 | 69,712 | 99,139 | 147,315 | 217,781 |
| Receivables | 1,015 | 3,162 | 1,880 | 1,784 | 970 |
| TOTAL | $66,698 | $99,079 | $144,756 | $195,569 | $294,936 |
| Non-Current Assets | |||||
| PPE Net | 4,031 | 6,111 | 10,372 | 13,192 | 11,461 |
| Intangibles | 48,690 | 48,690 | 158,567 | 172,463 | 29,759 |
| Other Non-Current Assets | 3,514 | 1,929 | 1,929 | 2,134 | 1,428 |
| TOTAL | $56,235 | $56,730 | $170,868 | $187,789 | $42,648 |
| Total Assets | $122,933 | $155,809 | $315,624 | $383,358 | $337,584 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 6,566 | 4,826 | N/A |
| Accounts payable and accrued liabilities | 1,174 | 1,069 | 1,715 | 1,740 | 1,506 |
| Accrued Expenses | 6,499 | 7,007 | 19,455 | 28,657 | 24,316 |
| Other current liabilities | 2,026 | 4,526 | N/A | N/A | 4,418 |
| TOTAL | $11,643 | $12,602 | $27,736 | $35,223 | $30,240 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 17,264 | 19,147 | 51,519 | 82,704 | 17,239 |
| TOTAL | $17,264 | $19,147 | $51,519 | $82,704 | $17,239 |
| Total Liabilities | $28,907 | $31,749 | $79,255 | $117,927 | $47,479 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,575 | 12,440 | 9,410 | 8,218 | 6,584 |
| Common Shares | 17 | 12 | 9 | 121 | 99 |
| Retained earnings | -1,013,316 | -962,438 | -812,517 | -719,486 | -590,956 |
| Other shareholders' equity | 2,619 | 2,583 | 2,564 | 2,541 | 2,307 |
| TOTAL | $94,026 | $124,060 | $236,369 | $265,431 | $290,105 |
| Total Liabilities And Equity | $122,933 | $155,809 | $315,624 | $383,358 | $337,584 |